tiprankstipranks
SAGE Therapeutics (SAGE)
NASDAQ:SAGE

SAGE Therapeutics (SAGE) Ownership - Who Owns SAGE Therapeutics?

850 Followers

SAGE Therapeutics (SAGE) Ownership Overview

7.92%35.58%19.80%36.71%
19.80% Other Institutional Investors
36.71% Public Companies and
Individual Investors
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 55.37% of the company’s stock is owned by Institutional Investors, 7.92% is owned by Insiders and 36.71% is owned by Public Companies and Individual Investors.
The ownership structure of SAGE Therapeutics (SAGE) stock is a mix of institutional, retail and individual investors. Approximately 55.37% of the company’s stock is owned by Institutional Investors, 7.92% is owned by Insiders and 36.71% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date
Name
Activity
Value
Jan 04, 2024
Kimi Iguchi
Cfo & Treasurer
Bought$2233
Aug 11, 2023Bought$37260
May 11, 2023Bought$50500

Recent Hedge Fund Trading Activity

Date
Firm
Activity
Value
Dec 31, 2023Bought$153120
Dec 31, 2023Sold$1624166
Dec 31, 2023Bought$2595654
Dec 31, 2023Bought$9351016

Top Shareholders

Holder
# of Shares
Type
% Holding
Value
4,866,258Institution8.10%63,431,673
4,388,284Institution7.30%57,201,282
4,304,671Institution7.16%56,111,386
3,150,533Institution5.24%41,067,198
2,975,637Institution4.95%38,787,428
2,401,695Institution4.00%31,306,094
2,124,699Insider3.53%27,695,451
1,232,649Insider2.05%16,067,580
969,906Institution1.61%12,642,725
606,168Institution1.01%7,901,400

Top Mutual Fund Holders

Holder
# of Shares
Type
% Holding
Value
4,388,284Institution7.30%57,201,282
4,304,671Institution7.16%56,111,386
2,975,637Institution4.95%38,787,428
969,906Institution1.61%12,642,725
606,168Institution1.01%7,901,400
579,852Institution0.96%7,558,371
565,475Institution0.94%7,370,967
534,062Institution0.89%6,961,498
472,445Institution0.79%6,158,321
453,869Institution0.76%5,916,182

Top ETF Holders

Holder
# of Shares
Type
% Holding
Value
3,081,855Institution5.13%38,738,917
1,593,487Institution2.65%29,861,946
1,304,612Institution2.17%24,448,429
1,253,358Institution2.09%16,337,522
786,486Institution1.31%14,738,748
737,823Institution1.23%13,826,803
425,867Institution0.71%5,551,176
365,452Institution0.61%4,763,667
196,809Institution0.33%3,688,201
185,830Institution0.31%3,482,454

FAQ

Who Owns SAGE Therapeutics (SAGE)?
According to the latest TipRanks data, approximately 19.80% of the company's stock is held by institutional investors, 7.92% is held by insiders, and 36.71% is held by retail investors.
    What percentage of SAGE Therapeutics (SAGE) stock is held by institutional investors?
    According to the latest TipRanks data, approximately 19.80% of SAGE Therapeutics (SAGE) stock is held by institutional investors.
      What percentage of SAGE Therapeutics (SAGE) stock is held by retail investors?
      According to the latest TipRanks data, approximately 36.71% of SAGE Therapeutics (SAGE) stock is held by retail investors.
        Who owns the most shares of SAGE Therapeutics (SAGE)?
        Vanguard owns the most shares of SAGE Therapeutics (SAGE).
          What is the significance of the ownership structure for a publicly traded company?
          The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.
            What's Included in PREMIUM?
            Make informed decisions based on Top Analysts' activity
            Know what industry insiders are buying
            Get actionable alerts from top Wall Street Analysts
            Find out before anyone else which stock is going to shoot up
            Get powerful stock screeners & detailed portfolio analysis